These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37827326)

  • 1. TRIP6 disrupts tight junctions to promote metastasis and drug resistance and is a therapeutic target in colorectal cancer.
    Gou H; Wong CC; Chen H; Shang H; Su H; Zhai J; Liu W; Liu W; Sun D; Wang X; Yu J
    Cancer Lett; 2023 Dec; 578():216438. PubMed ID: 37827326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TTPAL Promotes Colorectal Tumorigenesis by Stabilizing TRIP6 to Activate Wnt/β-Catenin Signaling.
    Gou H; Liang JQ; Zhang L; Chen H; Zhang Y; Li R; Wang X; Ji J; Tong JH; To KF; Sung JJY; Chan FKL; Fang JY; Yu J
    Cancer Res; 2019 Jul; 79(13):3332-3346. PubMed ID: 31018940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-induced Nur77 activates PI3K/Akt signaling
    Shi Z; To SKY; Zhang S; Deng S; Artemenko M; Zhang M; Tang J; Zeng JZ; Wong AST
    Theranostics; 2021; 11(7):3376-3391. PubMed ID: 33537093
    [No Abstract]   [Full Text] [Related]  

  • 4. TRIP6, as a target of miR-7, regulates the proliferation and metastasis of colorectal cancer cells.
    Ling Y; Cao C; Li S; Qiu M; Shen G; Chen Z; Yao F; Chen W
    Biochem Biophys Res Commun; 2019 Jun; 514(1):231-238. PubMed ID: 31029422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NKX6.1 Represses Tumorigenesis, Metastasis, and Chemoresistance in Colorectal Cancer.
    Chung HH; Lee CT; Hu JM; Chou YC; Lin YW; Shih YL
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32707737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
    Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
    Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NUBPL, a novel metastasis-related gene, promotes colorectal carcinoma cell motility by inducing epithelial-mesenchymal transition.
    Wang Y; Wu N; Sun D; Sun H; Tong D; Liu D; Pang B; Li S; Wei J; Dai J; Liu Y; Bai J; Geng J; Fu S; Jin Y
    Cancer Sci; 2017 Jun; 108(6):1169-1176. PubMed ID: 28346728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. USP22 drives colorectal cancer invasion and metastasis via epithelial-mesenchymal transition by activating AP4.
    Li Y; Yang Y; Li J; Liu H; Chen F; Li B; Cui B; Liu Y
    Oncotarget; 2017 May; 8(20):32683-32695. PubMed ID: 28427243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
    Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L
    Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ponicidin inhibits pro-inflammatory cytokine TNF-α-induced epithelial-mesenchymal transition and metastasis of colorectal cancer cells via suppressing the AKT/GSK-3β/Snail pathway.
    Zhang Z; Xu J; Liu B; Chen F; Li J; Liu Y; Zhu J; Shen C
    Inflammopharmacology; 2019 Jun; 27(3):627-638. PubMed ID: 30244296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Myb promotes growth and metastasis of colorectal cancer through c-fos-induced epithelial-mesenchymal transition.
    Qu X; Yan X; Kong C; Zhu Y; Li H; Pan D; Zhang X; Liu Y; Yin F; Qin H
    Cancer Sci; 2019 Oct; 110(10):3183-3196. PubMed ID: 31338937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
    Yang Z; Wu D; Chen Y; Min Z; Quan Y
    Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MEGF6 Promotes the Epithelial-to-Mesenchymal Transition via the TGFβ/SMAD Signaling Pathway in Colorectal Cancer Metastasis.
    Hu H; Wang M; Wang H; Liu Z; Guan X; Yang R; Huang R; Tang Q; Zou C; Wang G; Gao X; Wang X
    Cell Physiol Biochem; 2018; 46(5):1895-1906. PubMed ID: 29719292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SERPINC1, a new prognostic predictor of colon cancer, promote colon cancer progression through EMT.
    Le Z; Chen S; Feng Y; Lu W; Liu M
    Cancer Rep (Hoboken); 2024 Jun; 7(6):e2079. PubMed ID: 38923313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PI3K/AKT-mediated upregulation of WDR5 promotes colorectal cancer metastasis by directly targeting ZNF407.
    Tan X; Chen S; Wu J; Lin J; Pan C; Ying X; Pan Z; Qiu L; Liu R; Geng R; Huang W
    Cell Death Dis; 2017 Mar; 8(3):e2686. PubMed ID: 28300833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIP6 promotes tumorigenic capability through regulating FOXC1 in hepatocellular carcinoma.
    Wang F; Zhang B; Xu X; Zhu L; Zhu X
    Pathol Res Pract; 2020 Apr; 216(4):152850. PubMed ID: 32046874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay between Trx-1 and S100P promotes colorectal cancer cell epithelial-mesenchymal transition by up-regulating S100A4 through AKT activation.
    Zuo Z; Zhang P; Lin F; Shang W; Bi R; Lu F; Wu J; Jiang L
    J Cell Mol Med; 2018 Apr; 22(4):2430-2441. PubMed ID: 29383839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRIP6 regulates p27 KIP1 to promote tumorigenesis.
    Lin VT; Lin VY; Lai YJ; Chen CS; Liu K; Lin WC; Lin FT
    Mol Cell Biol; 2013 Apr; 33(7):1394-409. PubMed ID: 23339869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfatase-2 promotes the growth and metastasis of colorectal cancer by activating Akt and Erk1/2 pathways.
    Tao Y; Han T; Zhang T; Sun C
    Biomed Pharmacother; 2017 May; 89():1370-1377. PubMed ID: 28320104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.